Combining biomarkers to detect disease with application to prostate cancer

Author： Etzioni* R.   Kooperberg C.   Pepe M.   Smith R.   Gann P.H.  

Publisher： Oxford University Press

ISSN： 1465-4644

Source： Biostatistics, Vol.4, Iss.4, 2003-10, pp. : 523-538

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate atypia: Does repeat biopsy detect clinically significant prostate cancer?

By  

THE PROSTATE, Vol. 75, Iss. 7, 2015-05 ,pp. : 673-678

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biomarkers to guide therapy or surveillance for prostate cancer

By Citrin Deborah   Hudak Kathryn   Camphausen Kevin A  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 827-829

Future Medicine

Access to resources Recommend Favorite

Circulating nucleic acids as biomarkers of prostate cancer

By Sita-Lumsden Ailsa   Fletcher Claire E   Dart D Alwyn   Brooke Greg N   Waxman Jonathan   Bevan Charlotte L  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 867-877

Future Medicine

Access to resources Recommend Favorite

Biomarkers for prostate cancer: who will benefit from local treatment, who harbors occult systemic disease and who needs treatment at all?

By Citrin Deborah   Camphausen Kevin A  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 823-825

Future Medicine

Access to resources Recommend Favorite

Usefulness of the (F/T)/PSA Density Ratio to Detect Prostate Cancer

By  

Urologia Internationalis, Vol. 74, Iss. 1, 2005-01 ,pp. : 13-18

Karger

Access to resources Recommend Favorite